Not professing skills in this area but attracted to company by its client list

Pfizer, Johnson&Johnson, Roche and Novartis all clients to name but a few

Company effectively reproduces human response to possible drugs, creams etc . Effectively builds a"virtual patient". Others do this but not sure they have the client list

Seems to get repeat business plus looks to be on c2x - 2.5x sales year just ended. IMHO too low for such a stock. Recent news in Feb all good and suggests on certain ventures they get some interest in new compunds developed

Listed above this price -- 85p --- this time last year. Results should be in next few weeks. Any thoughts?

Sales warnings ---- profit warning

Apologies for starting thread -- effectively a whipping boy for the major pharmas

Price taker not maker

Apologies again

Confi, thanks for the honest update. Luckily I didn't get around to buying this one!

One can't be right all the time, so don't be too hard on yourself. :o)

Just a thought, though: keep watching it on the down, as could become a bargain again!

Don't beat yourself up over it!!!
You started the thread with integrity.
That is the important point. It is those that start them without integrity that should apologise.
Just glad I never got in, though I was watching it!! ;-)
Alan

thx for the comments. Will stay away from this now, as can't see good news or a profit for long time given they say an adjustment to business will be needed to cut costs